ANO5

Chr 11

anoctamin 5

Also known as: GDD1, LGMD2L, LGMDR12, TMEM16E

This gene encodes a member of the anoctamin family of transmembrane proteins. The encoded protein is likely a calcium activated chloride channel. Mutations in this gene have been associated with gnathodiaphyseal dysplasia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]

GeneReviewsResearchGenerating clinical summary…
GOFmechanismLOEUF 0.95
VCEP Guidelines: Limb Girdle Muscular DystrophyReleased
ClinGen Panel
Clinical SummaryANO5
🧬
Gene-Disease Validity (ClinGen)
gnathodiaphyseal dysplasia · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
207 unique Pathogenic / Likely Pathogenic· 757 VUS of 1543 total submissions
💊
Clinical Trials
2 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — ANO5
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.95LOEUF
pLI 0.000
Z-score 1.86
OE 0.73 (0.570.95)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.12Z-score
OE missense 0.98 (0.911.06)
467 obs / 474.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.73 (0.570.95)
00.351.4
Missense OE?0.98 (0.911.06)
00.61.4
Synonymous OE?1.18
01.21.6
LoF obs/exp: 42 / 57.2Missense obs/exp: 467 / 474.2Syn Z: -1.80
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateANO5-related gnathodiaphyseal dysplasiaGOFAD

This gene — mechanism propensity

DN
0.7228th %ile
GOF
0.76top 25%
LOF
0.2385th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFGain of function of TMEM16E/ANO5 scrambling activity caused by a mutation associated with gnathodiaphyseal dysplasia.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 29124309

ClinVar Variant Classifications

1543 submitted variants in ClinVar

Classification Summary

Pathogenic110
Likely Pathogenic97
VUS757
Likely Benign406
Benign72
Conflicting91
110
Pathogenic
97
Likely Pathogenic
757
VUS
406
Likely Benign
72
Benign
91
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
84
12
14
0
110
Likely Pathogenic
64
24
9
0
97
VUS
19
596
130
12
757
Likely Benign
1
9
241
155
406
Benign
0
2
67
3
72
Conflicting
91
Total1686434611701,533

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

17 pathogenic / likely-pathogenic (of 42) ClinVar copy-number / structural variants overlap ANO5 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ANO5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.